Market Place
Sourcing Support
Crestone`s Antibiotic Outperforms Vancomycin For C. Diff In Phase 2
05 Sep 2024 //
FIERCE BIOTECH
Crestone Reports Positive Phase 2 Data for CRS3123 in C. Difficile Infections
05 Sep 2024 //
BUSINESSWIRE
Crestone and Praedicare to Publish Data on the Novel Antibiotic CRS0540
15 Aug 2022 //
PRNEWSWIRE
Crestone Joins Antimicrobials Working Group
08 Jun 2021 //
PRNEWSWIRE
Crestone Enrolls First Patient in Phase 2 Trial for Novel Antibiotic CRS3123
07 Jun 2021 //
BIOSPACE
Crestone, Inc. Secures NIH Funding for Development Through Phase 1 CRS0540
30 Jun 2020 //
BUSINESSWIRE
Crestone (Boulder, Colorado) Secures NIH Funding for Preclinical CRS3123
27 Apr 2020 //
BIOSPACE
Crestone, Inc. (Boulder) Secures CFF Funding for Preclinical Devp
13 Jan 2020 //
BUSINESSWIRE
Crestone Boulder Secures NIH Funding Pha2 Trial of Novel Antibiotic Candidate
13 Sep 2019 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.